Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation
- 29 February 2008
- journal article
- Published by Elsevier BV in Transplant Immunology
- Vol. 18 (4), 319-323
- https://doi.org/10.1016/j.trim.2007.08.005
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Graft-versus-host diseaseNature Reviews Immunology, 2007
- Validation of Immunological Biomarkers for the Pharmacodynamic Monitoring of Immunosuppressive Drugs in HumansTherapeutic Drug Monitoring, 2007
- Immunosuppressive Therapy and Malignancy in Organ Transplant RecipientsDrugs, 2007
- Impact of Tacrolimus and Mycophenolate Mofetil Combination on Cardiovascular Risk Profile after Kidney TransplantationJournal of the American Society of Nephrology, 2006
- Strategies for the prevention of infection after solid organ transplantationExpert Review of Anti-infective Therapy, 2006
- Overcoming Barriers to Long-Term Graft SurvivalAmerican Journal of Kidney Diseases, 2006
- The future of immunosuppression: a personal viewTransplantation Proceedings, 2004
- Naphthoquinone Derivatives and Lignans from the Paraguayan Crude Drug “Tayï Pytá” (Tabebuia heptaphylla, Bignoniaceae)Zeitschrift für Naturforschung C, 2003
- The in vivo effect of rapamycin derivative SDZ RAD on lymphocyte proliferationTransplantation Proceedings, 1998
- History of drugs for thrombotic disease. Discovery, development, and directions for the future.Circulation, 1994